CAS 71447-49-9
:acétate d'hormone de libération de l'hormone lutéinisante
- Luteinizing Hormone-Releasing Hormone human acetate salt
- Gonadorelin diacetate
Gonadorelin diacetate
CAS :Formule :C59H83N17O17Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1302.3940Gonadorelin Diacetate
CAS :Formule :C55H75N17O13·C2H4O2Couleur et forme :White To Off-White SolidMasse moléculaire :1182.31 2*60.05Gonadorelin Acetate (33515-09-2 free base)
CAS :Gonadorelin Acetate (33515-09-2 free base) (Luteinizing Hormone Releasing Hormone (LH-RH)) is hypothalamic neuropeptide which plays a key role in the control ofFormule :C59H83N17O17Degré de pureté :99.42% - 99.46%Couleur et forme :White Or Off-White PowderMasse moléculaire :1302.39Luteinizing Hormone Releasing Hormone LH-RH
CAS :Peptide Luteinizing Hormone Releasing Hormone LH-RH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.Formule :C55H75N17O13Masse moléculaire :1,182.4 g/molLH-RH (Human)
CAS :Produit contrôléLuteinizing hormone-releasing hormone (LH-RH), also known as Gonadotropin-Releasing Hormone (GnRH), stimulates the pituitary gland’s production and secretion of luteinizing hormone and follicle-stimulating hormone. LHRH is a decapeptide and is itself secreted by the hypothalamus. It is crucial for human reproduction and is heavily involved in the regulation of ovulation, sexual development and the onset of puberty.
When secreted, GNRH binds to the G-protein coupled receptor, gonadotropin-releasing hormone receptor (GNRHR) located on pituitary gonadotrophic cells in the anterior pituitary.
Medically, the understanding of GnRH is paramount, due to its involvement in the pathogensis of central hypogonadism. Any obstructions to its function in the reproductive system can result in the development of human pathologically conditions. It is important to note that analogs of GnRH can be used in pharmacology, in the treatment of gynaecological diseases, through blocking the secretion of estrogen secretion from the ovary. Additional GNRH analogs can be used to treat ovarian cancer, hormone-dependent cancers, endometriosis and modality in infertility. Therefore this product is a useful research tool.Formule :C55H75N17O13•2CH3COOHDegré de pureté :Min. 95%Masse moléculaire :1,302.4 g/molLH-RH (Human)
CAS :Luteinizing hormone-releasing hormone (LH-RH), also known as Gonadotropin-Releasing Hormone (GnRH), stimulates the pituitary gland’s production and secretion of luteinizing hormone and follicle-stimulating hormone. LHRH is a decapeptide and is itself secreted by the hypothalamus. It is crucial for human reproduction and is heavily involved in the regulation of ovulation, sexual development and the onset of puberty. When secreted, GNRH binds to the G-protein coupled receptor, gonadotropin-releasing hormone receptor (GNRHR) located on pituitary gonadotrophic cells in the anterior pituitary. Medically, the understanding of GnRH is paramount, due to its involvement in the pathogensis of central hypogonadism. Any obstructions to its function in the reproductive system can result in the development of human pathologically conditions. It is important to note that analogs of GnRH can be used in pharmacology, in the treatment of gynaecological diseases, through blocking the secretion of estrogen secretion from the ovary. Additional GNRH analogs can be used to treat ovarian cancer, hormone-dependent cancers, endometriosis and modality in infertility. Therefore this product is a useful research tool and is available in a 0.5mg vial.Formule :C55H75N17O13•(C2H4O2)2Degré de pureté :Min. 95%Masse moléculaire :1,302.4 g/molLuteinizing Hormone Releasing Hormone LH-RH
CAS :Custom research peptide; min purity 95%.Formule :C55H75N17O13Degré de pureté :Min. 95%Masse moléculaire :1,182.4 g/mol






